Vivo Bio Tech Limited announced the expiry of 6.27 lakh convertible equity warrants.

These warrants, part of a 25 lakh issue to Dwight Technologies Private Limited at Rs. 45 each, were not exercised within their 18-month tenure.

This means the company will not receive the expected capital from these specific warrants, and the potential equity dilution from them is avoided.

This update clarifies the company's capital structure.